BC
TWST icon

Brookfield Corp’s Twist Bioscience TWST Stock Holding History

Brookfield Corp’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,716
Closed -$242K – 571
2020
Q4 		$242K Sell
1,716
-7,389
-81% -$820K ﹤0.01% 424
2020
Q3 		$692K Buy
+9,105
New +$567K ﹤0.01% 322

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Brookfield Corp's TWST Position: Q1 2021 in Review

Brookfield Corp sold out of Twist Bioscience (TWST) in Q1 2021, closing a stake of 1,716 shares — an estimated $242K sold.

Brookfield Corp first reported a position in TWST in Q3 2020 and held it in 2 quarters. The position peaked at $692K in Q3 2020. 240 funds tracked by Wall St. Rank hold TWST as of Q1 2021.

  • Brookfield Corp reported no remaining Twist Bioscience position as of Q1 2021 after selling out during the quarter.
  • Brookfield Corp sold 1,716 Twist Bioscience shares in Q1 2021, an estimated $242K.
  • Brookfield Corp first reported a position in Twist Bioscience in Q3 2020 and held it in 2 quarters.
  • Brookfield Corp's Twist Bioscience position peaked at $692K in Q3 2020.
  • 240 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2021.

Based on Brookfield Corp's 13F filing for Q1 2021, filed 17 May 2021.